View More Recent Stories

May 27, 2025 10:49AM William Blair Reiterates Outperform Rating on Rocket Pharmaceuticals (RCKT)
May 27, 2025 08:10AM BMO Capital on Rocket Pharmaceuticals (RCKT): 'we expect today's announcement...to significantly pressure RCKT'
May 27, 2025 08:07AM Jefferies on Rocket Pharmaceuticals (RCKT): 'We expect significant stock weakness'
May 27, 2025 08:06AM Rocket Pharmaceuticals (RCKT) PT Lowered to $32 at BofA Securities
May 27, 2025 08:05AM Morgan Stanley on Rocket Pharmaceuticals (RCKT): 'we expect RCKT shares to be under significant pressure today'
May 27, 2025 08:04AM JPMorgan on Rocket Pharmaceuticals (RCKT): 'we wouldn’t be surprised by shares continuing to be under pressure'
May 27, 2025 07:01AM Rocket Pharmaceuticals (RCKT) Provides Update on Phase 2 Trial of RP-A501
May 16, 2025 06:40AM Rocket Pharmaceuticals Price Target Raised to $30.00 at Cantor Fitzgerald (RCKT)
May 16, 2025 06:34AM Rocket Pharmaceuticals (RCKT) PT Lowered to $18 at Evercore ISI
May 15, 2025 03:15PM Rocket Pharmaceuticals (RCKT) Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy
May 8, 2025 08:18PM Rocket Pharmaceuticals (RCKT) Tops Q1 EPS by 3c
Apr 8, 2025 09:05AM BMO Capital: 'Rocket Pharmaceuticals (RCKT) Poised for an Asymmetric Rebound in 2Q25+'
Apr 2, 2025 07:04AM Smid cap biotech investors must stop chasing binary events says Cantor Fitzgerald
Mar 24, 2025 07:26AM Cantor Fitzgerald Reiterates Overweight Rating on Rocket Pharmaceuticals (RCKT)
Mar 17, 2025 07:06AM Cantor Fitzgerald says 15% of biotech companies down 40% or more
Mar 11, 2025 04:10PM BMO Capital Starts Rocket Pharmaceuticals (RCKT) at Outperform
Mar 3, 2025 06:57AM Rocket Pharmaceuticals (RCKT) PT Raised to $52 at Scotiabank
Mar 3, 2025 06:43AM Rocket Pharmaceuticals (RCKT) PT Lowered to $36 at Canaccord Genuity
Feb 28, 2025 07:38AM Rocket Pharmaceuticals (RCKT) PT Lowered to $50 at Cantor Fitzgerald
Feb 27, 2025 05:01PM Rocket Pharmaceuticals (RCKT) Tops Q4 EPS by 10c
Dec 18, 2024 03:59AM Jefferies Starts Rocket Pharmaceuticals (RCKT) at Buy
Dec 11, 2024 07:01AM Rocket Pharmaceuticals (RCKT) Prices Upsized 13.2M Share Offering at $12.50/sh
Dec 10, 2024 04:50PM After-hours movers: GM, Stitch Fix, Dave & Buster's, GME and more
Dec 10, 2024 04:01PM Rocket Pharmaceuticals (RCKT) Announces Proposed Public Offering of Common Stock
Nov 19, 2024 06:51AM Canaccord Genuity Reiterates Buy Rating on Rocket Pharmaceuticals (RCKT)
Nov 18, 2024 11:00AM Rocket Pharmaceuticals (RCKT) Announces New England Journal of Medicine Publication of Phase 1 RP-A501 Long-Term Data
Nov 11, 2024 07:17AM Rocket Pharmaceuticals (RCKT) PT Raised to $39 at Canaccord Genuity
Nov 8, 2024 06:39AM Rocket Pharmaceuticals (RCKT) Tops Q3 EPS by 4c
Sep 18, 2024 07:25AM Canaccord Genuity Reiterates Buy Rating on Rocket Pharmaceuticals (RCKT)
Sep 17, 2024 08:36AM Morgan Stanley on Rocket Pharmaceuticals (RCKT): 'we are encouraged by rapid enrollment'
Sep 17, 2024 07:03AM Rocket Pharmaceuticals (RCKT) Announces Completion of Enrollment in Phase 2 Pivotal Trial of RP-A501 for the Treatment of Danon Disease
Sep 10, 2024 07:03AM Rocket Pharmaceuticals (RCKT) Appoints Mikael Dolsten to its Board
Aug 16, 2024 04:08PM Rocket Pharmaceuticals (RCKT) Files Mixed Shelf
Aug 7, 2024 06:59AM Rocket Pharmaceuticals (RCKT) PT Lowered to $38 at Canaccord Genuity
Aug 5, 2024 05:20PM Rocket Pharmaceuticals (RCKT) Misses Q2 EPS by 2c
Jul 3, 2024 06:32AM Rocket Pharmaceuticals (RCKT) PT Lowered to $40 at Canaccord Genuity
Jun 28, 2024 07:56AM Rocket Pharmaceuticals (RCKT) to Resume Trading at 8 a.m.
Jun 28, 2024 07:28AM Rocket Pharmaceuticals (RCKT) Provides Regulatory Update on KRESLADI
Jun 28, 2024 06:57AM Rocket Pharmaceuticals (RCKT) Halted, News Pending
View More Recent Stories